Sorry, sorry, sorry
BMJ 2010; 340 doi: https://doi.org/10.1136/bmj.c727 (Published 10 February 2010) Cite this as: BMJ 2010;340:c727- Ike Iheanacho, editor, Drug and Therapeutics Bulletin
- iiheanacho{at}bmjgroup.com
Look as hard as you like. Scrutinise the text very, v-e-e-r-y . . . s-l-o-w-l-y. Then, to make sure, use your internet browser as a bloodhound to sniff for buried words such as “regret,” “apologise,” or “sorry.” Ultimately, though, you’ll conclude that they’re just not there.
Nowhere in the recent announcement from the European Medicines Agency of its suspension of the licence for the antiobesity drug sibutramine (Reductil) (see BMJ 2010;340:c477, doi:10.1136/bmj.c477) is there anything suggesting remorse on its part. Instead the impression is of business as usual: a …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.